Now, one type of weight-loss medication is proving helpful with another health issue. In a study published Feb. 12 in JAMA ...

private health insurer Vitality has become the country’s first provider to offer customers discounted weight-loss treatments, such as Wegovy and Mounjaro. Speaking to Yahoo UK, chief commercial ...

The first clinical trial of its kind found the weekly semaglutide jab cuts the amount people drink in one day by 40 per cent ...

Weight-loss injections slash alcohol cravings and ... while there were also bigger reductions in heavy drinking over time compared to the placebo group. Nearly 40% of people in the semaglutide ...

Novo Nordisk, the Danish pharmaceutical giant that makes Ozempic and Wegovy, used a submission ... earned more than $100 million from weight-loss services over the past 18 months from its ...

Novo Nordisk's 2024 earnings exceeded estimates, with strong performance in diabetes, obesity, and rare disease segments.

Company reported positive Phase 2b QUALITY study topline results for enobosarm + semaglutide (Wegovy®) with study meeting prespecified primary endpoint of preservation of lean mass as well as greater ...

However, the European Medicines Agency approved it on the grounds that “Wegovy’s benefits ... to try anything to lose weight. “I think I was so low at that time I would have taken anything ...

It also adds to a growing body of evidence that the drug may have benefits beyond weight loss or controlling diabetes ... reductions in heavy drinking over time compared to the placebo group.

Novo Nordisk shares dropped due to CagriSema trial results but have long-term upside. Learn why NVO stock is a Strong Buy ...